Dilated Cardiomyopathies



Dilated Cardiomyopathies





Clinical and Echocardiographic Overview

Cardiomyopathy represents a diverse group of diseases intrinsic to the myocardium. By strict definition, they are a primary disorder of the heart muscle and are not related to valve disease, hypertension, or coronary artery disease. From a practical standpoint, severe dysfunction due to diffuse coronary disease and chronic ischemia is considered a form of cardiomyopathy (ischemic cardiomyopathy). Traditionally, cardiomyopathies are divided into dilated (or congestive) and nondilated or restrictive forms. Some cardiomyopathies may present as either a dilated or restrictive form. An additional subset includes true hypertrophic cardiomyopathy, which can either be nonobstructive or obstructive. This chapter deals with dilated cardiomyopathy. Restrictive, hypertrophic, and other cardiomyopathies will be addressed in Chapter 19.


Dilated Cardiomyopathy

There are multiple etiologies for dilated cardiomyopathy (Table 18.1). Clinically, cardiomyopathies share a constellation of symptoms that can be present to varying degrees, including congestive heart failure, low-output state, fatigue, dyspnea, arrhythmias, and sudden cardiac death. Echocardiography serves as a definitive tool for establishing the presence and severity of cardiomyopathy. It may provide information regarding the specific etiology and can be used to accurately track the physiologic abnormalities associated with the cardiomyopathy. The American College of Cardiology/American Heart Association guidelines for management of congestive heart failure consider echocardiography a class I diagnostic test, implying that it is generally indicated and useful in all patients with congestive heart failure and suspected cardiomyopathy. Its use is considered appropriate in a broad range of situations in patients with known or suspected cardiomyopathy (Table 18.2). Echocardiographic imaging can provide valuable prognostic information and serve as a guide to the success of therapy.

Although the primary diagnostic features of dilated cardiomyopathy are left ventricular dilation and systolic dysfunction, secondary features are common and contribute substantially to symptoms and prognosis. These include diastolic dysfunction with chronic elevation of left atrial pressure, secondary mitral and tricuspid regurgitation, secondary pulmonary hypertension, and concurrent right ventricular dysfunction. The primary and secondary abnormalities seen in dilated cardiomyopathy are listed in Table 18.3. The most common clinical presentation of dilated cardiomyopathy is congestive heart failure with shortness of breath and exercise intolerance. Depending on severity and duration, patients with dilated cardiomyopathy may be asymptomatic, or present with New York Heart Association class I to IV symptoms.

The echocardiographic features of dilated cardiomyopathy parallel the primary and secondary findings noted in Table 18.3. Left ventricular dilation is ubiquitous and a requisite component for establishing the diagnosis. The degree of dilation can be mild or substantial, with left ventricular internal dimensions of 9.0 cm or more occasionally encountered. The distribution of systolic dysfunction within the left ventricular walls is dependent on whether the cardiomyopathy has an ischemic etiology. If an ischemic etiology is present, there usually is greater regional variation in systolic dysfunction than if the process is nonischemic. It should be emphasized, however, that in documented nonischemic cardiomyopathy, there is regional variation in systolic dysfunction, typically with the proximal inferoposterior and posterior lateral walls having relatively preserved function. As a consequence of dilation and systolic dysfunction, the left ventricle takes on more spherical geometry that further
contributes to the deterioration of systolic function because the spherical geometry interferes with contractile efficiency. Normally, the long axis dimension of the left ventricle exceeds the minor axis dimension (diameter) with a ratio of 1.6:1 or greater. With progressive dilation, the minor axis increases disproportionally, and the ratio of long to minor axis decreases. Typically, a ratio (sphericity index) of less than 1.5:1 implies pathologic remodeling. The increasing spherical geometry results in apical and lateral displacement of the papillary muscles. This effectively reduces the length of the mitral apparatus and results in functional mitral regurgitation.








Table 18.1 Classification of Cardiomyopathy and Diseases Resulting in Acute or Chronic Left Ventricular Dysfunction































































































































Dilated cardiomyopathy



Idiopathic cardiomyopathy



Familial cardiomyopathy



Noncompacted myocardium



Peripartum cardiomyopathy



Hemochromatosis



Infectious




Postviral myocarditis




Human immunodeficiency virus related




Legionella infection




Sepsis (Gram negative)



Toxic cardiomyopathy




Adriamycin




Alcohol




Carbon monoxide poisoning




Other chemotherapy


High-output cardiomyopathy



Tachycardia-mediated cardiomyopathy



Thyrotoxicosis



Nutritional (beriberi, thiamine deficiency)



Peripheral left-to-right shunt lesions



Anemia


Hypertrophic cardiomyopathy



Asymmetric septal hypertrophy (idiopathic hypertrophic cardiomyopathy)




Obstructive versus nonobstructive



Concentric hypertrophic cardiomyopathy



Isolated apical hypertrophic cardiomyopathy



Atypical hypertrophic cardiomyopathy


Restrictive cardiomyopathy



Idiopathic



Infiltrative




Amyloidosis




Glycogen storage diseases




Hemochromatosis



Postradiation therapy



Endocardial fibroelastosis


Other



Friedreich ataxia



Muscular dystrophies









Table 18.2 Appropriateness Criteria for Echocardiography in Cardiomyopathy and Congestive Heart Failure






























































Indication


Appropriateness Score (1-9)


1.


Symptoms potentially due to suspected cardiac etiology, including but limited to dyspnea, shortness of breath, lightheadedness, syncope, TIA, cerebrovascular events.


A (9)


2.


Prior testing that is concerning for heart disease (i.e., chest x-ray, baseline scout images for stress echocardiogram, ECG, elevation of serum BNP.


A (8)


7.


Evaluation of LV function with prior ventricular function evaluation within the past year with normal function (such as prior echocardiogram, LV gram, SPECT, cardiac MRI) in patients in whom there has been no change in clinical status.


I (2)


11.


Evaluation of hypotension or hemodynamic instability of uncertain or suspected cardiac etiology.


A (9)


14.


Evaluation of respiratory failure with suspected cardiac etiology.


A (8)


41.


Initial evaluation of known or suspected heart failure (systolic or diastolic).


A (9)


42.


Routine (yearly) evaluation of patients with heart failure (systolic or diastolic) in whom there is no change in clinical status.


I (3)


43.


Reevaluation of known heart failure (systolic or diastolic) to guide therapy in a patient with a change in clinical status.


A (9)


44.


Evaluation for dyssynchrony in a patient being considered for CRT.


A (8)


45.


Patient with known implanted pacing device with symptoms possibly due to suboptimal pacing device settings to reevaluate for dyssynchrony and/or revision of pacing device settings.


A (8)


49.


Evaluation of suspected restrictive, infiltrative, or genetic cardiomyopathy.


A (9)


50.


Screening study for structure and function in first-degree relatives of patients with inherited cardiomyopathy.


A (9)


51.


Baseline and serial reevaluations in patients undergoing therapy with cardiotoxic agents.


A (9)


Reprinted with permission of the ACCF from Douglas PS, Khandheria B, Stainback RF, et al. ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography. J Am Coll Cardiol 2007;50(2):187-204.


BNP, B type natriuretic peptide; CRT, cardiac resynchronization therapy; ECG, electrocardiogram; LV, left ventricle; MRI, magnetic resonance imaging; SPECT, single photon emission computed tomography; TIA, transient ischemic attack.


Figures 18.1, 18.2, 18.3, 18.4, 18.5, 18.6, 18.7 and 18.8 depict several features of dilated cardiomyopathy. Notice in Figures 18.1 and 18.2 the relatively mild left ventricular dilation and preservation of normal ventricular geometry. When comparing diastolic and systolic frames, ventricular systolic dysfunction is clearly present, but the ejection fraction is reduced to only 35%. Figures 18.3 and 18.4 are more extreme examples of long-standing dilated cardiomyopathy in which the left ventricle has taken on more spherical geometry. Note the relationship of the maximal lateral dimension to the length, which is increased compared with the geometry seen in normal individuals and increased compared with the milder dilated cardiomyopathy presented in
Figure 18.1. Figure 18.5 depicts secondary mitral regurgitation due to apical and lateral displacement of the papillary muscles, resulting in abnormal coaptation of the mitral valve leaflets.








Table 18.3 Echocardiographic Abnormalities in Cardiomyopathy
































Left ventricular dilation



Increasing sphericity of left ventricular geometry



Apical and lateral displacement of papillary muscles




Functional mitral regurgitation



Left ventricular thrombus


Left atrial dilation



Atrial fibrillation



Left atrial thrombosis/stasis of blood


Pulmonary hypertension


Tricuspid regurgitation


Right ventricular dilation/dysfunction







FIGURE 18.1. Parasternal views recorded in a patient with a dilated cardiomyopathy. A: In the parasternal long-axis view, note the dilation of the left ventricle (65 mm) and left atrium (50 mm). B: In the short axis view, note the normal circular geometry of the left ventricle and the uniform wall thickness. In real-time, all walls are uniformly hypokinetic.






FIGURE 18.2. Apical four-chamber view recorded in the same patient as in Figure 18.1. In this example, normal left ventricular geometry has been preserved, with a long-axis dimension significantly greater than the short-axis dimension, as noted in the schematic in the upper left.

Figure 18.6 depicts a classic ischemic cardiomyopathy. Note the thin, scarred inferior and inferoposterior walls and generalized hypokinesis of the remaining walls. This image is consistent with an established extensive inferior myocardial infarction with milder degrees of secondary left ventricular dysfunction in the remaining segments, resulting in global systolic dysfunction and reduced ventricular performance.

There are several M-mode findings that have remained relevant in patients with systolic dysfunction. The first is the E-point to septal separation (EPSS) defined as the distance (in millimeters) from the anterior septum to the maximal early opening
point (E-point) of the mitral valve (Fig. 18.7). Because the internal dimension of the left ventricle is proportional to diastolic left ventricular volume and the maximal diastolic excursion of the mitral valve is proportional to mitral stroke volume, the ratio of the two dimensions will be proportional to the ejection fraction. As such, limited mitral valve opening (manifested by a greater distance between the E-point and the septum) is an indirect indicator of reduced ejection fraction. The normal EPSS is 6 mm, with progressively larger EPSS representing lower ejection fraction. Evaluation of aortic valve motion also provides clues to left ventricular performance. Normally, the aortic valve has crisp opening and closing points and as such opens as a “box” when imaged with M-mode echocardiography. Reduced forward flow results in a more gradual closure during systole so that there is rounding of the aortic valve closing due to reduced forward flow (Fig. 18.8).






FIGURE 18.3. Parasternal long-axis view recorded in a patient with a long-standing, idiopathic dilated cardiomyopathy revealing marked dilation of the left ventricle but relatively preserved left atrial and right ventricular size. In the real-time image, note the severe global hypokinesis and spherical geometry of the ventricle.






FIGURE 18.4. Apical four-chamber view recorded in a patient with a dilated cardiomyopathy and spherical ventricular geometry in which the long- and short-axis dimensions are essentially equal. This has resulted in lateral displacement of the papillary muscles and retraction of the mitral apparatus toward the apex.






FIGURE 18.5. Apical four-chamber view recorded in a patient with a nonischemic dilated cardiomyopathy. Note the biatrial enlargement as well as the left ventricular enlargement and global hypokinesis. In the color flow image, note the functional mitral regurgitation. In the upper panel, note the coaptation of the mitral valve well above the plane of the annulus (dotted line), which is also schematized. Both the tenting area and height, which are related to severity of functional mitral regurgitation, are as noted.






FIGURE 18.6. Parasternal long-axis view recorded in a patient with an ischemic cardiomyopathy. A: Recorded in end diastole. Note the dilated left ventricle and the relative preservation of ventricular septal thickness (upper arrows) as compared with the thinned posterior wall (PW) (lower arrows). B: End-systolic frame. Note the hypokinesis of the anterior septum and akinesis of the posterior wall.

An older, indirect, and nonvolumetric measure of left ventricular systolic function is measurement of the descent of the base of the heart. With ventricular contraction, there is motion of the
annulus of the heart toward the apex of ≥10 mm in normals. The magnitude of this motion can be determined with M-mode echocardiography or more recently has been evaluated using Doppler tissue imaging. In this technique, an M-mode cursor or a Doppler sample volume is placed in the lateral annulus or the proximal ventricular septum. The total excursion of the annulus toward the apex can then be measured (Fig. 18.9). For patients with global ventricular dysfunction, there is a direct relationship between annular excursion and left ventricular ejection fraction, such that the lower the systolic excursion, the lower the ejection fraction. This observation is only valid in the presence of global dysfunction.






FIGURE 18.7. M-mode echocardiograms recorded in two patients with cardiomyopathy and systolic dysfunction. In each case, note the increased E-point to septal separation (EPSS) indicative of reduced ejection fraction. The EPSS is (A) 1.2 cm and (B) 3.0 cm. This suggests that the ejection fraction for the patient represented in B is substantially worse than that in A. The inset in A demonstrates a classic B-bump in mitral valve closure. Note that the smooth continuation between the A point and the closure point (c) is interrupted by transient reopening of the mitral valve denoted by the B-bump.






FIGURE 18.8. M-mode echocardiogram recorded through the aortic valve in a patient with a dilated cardiomyopathy and reduced stroke volume. Note the gradual curved closure of the aortic valve at end-systole (arrow). This is due to progressively diminishing forward flow as a consequence of severe systolic dysfunction. The small inset in the upper left schematizes the normal opening and closing pattern of the aortic valve.

Once the diagnosis of cardiomyopathy has been established, it is clinically useful to quantify the degree of systolic dysfunction. Parameters from two-dimensional echocardiography that have diagnostic and prognostic importance include any of the linear- or area-based measurements of left ventricular size from which the derived parameters of fractional shortening and fractional area change can be calculated. In modern practice, quantitation of ventricular volumes and ejection parameters should be routinely performed in patients with cardiomyopathy. This is usually done by assessment of ventricular volumes from two- or three-dimensional echocardiography from which stroke volume and ejection fraction are calculated (Figs. 18.10 and 18.11).

Three-dimensional echocardiography has the ability to quantify left ventricular volumes throughout the cardiac cycle. Volumes can be calculated at end diastole and end systole from which stroke volume and ejection fraction can be calculated (Fig. 18.11). Regional volume changes can also be determined from this three-dimensional volume. Multiple studies have demonstrated the superiority of three-dimensional echocardiography over two-dimensional volume quantitation with respect to both absolute accuracy and reproducibility. Threedimensional echocardiography remains limited by reliance on
automatic edge detection algorithms, which may result in erroneous data in a poor-quality dataset where the entire endocardial border is not easily identified. Other newer techniques for quantifying systolic function include determination of regional or global strain with either Doppler tissue or speckle tracking algorithms (Fig. 18.12). Calculation of average or global strain throughout the entire perimeter of the left ventricle provides a parameter directly related to ejection fraction.






FIGURE 18.9. M-mode echocardiograms of the lateral mitral annulus recorded from the left ventricular apex. The top panel was recorded in a patient with normal ventricular function and annular excursion toward the apex is 15 mm. The middle panel was recorded in a patient with an ejection fraction of 42% and a dilated cardiomyopathy, note the annular excursion of 10 mm. The bottom panel was recorded in a patient with an ejection fraction of 21% and reveals annular excursion of 6 mm.






FIGURE 18.10. Apical four- and two-chamber views recorded in a patient with a nonischemic dilated cardiomyopathy from which diastolic (left panels) and systolic (right panels) frames have been used to calculate ventricular volumes using the rule of disks or Simpson’s method. The calculated volumes and subsequent ejection fraction for the four and two chamber as well as biplane methodology are as noted.






FIGURE 18.11. Calculation of end-diastolic volume (EDV) and end-systolic volume (ESV) in a patient using real-time three-dimensional echocardiography. The upper panels are the extracted four- and two-chamber views. The lower right is a shell based on the three-dimensional volume, from which EDV and ESV as well as stroke volume (SV) and ejection fraction (EF) are calculated.


Doppler Evaluation of Systolic and Diastolic Function

The use of Doppler techniques to determine systolic and diastolic dysfunction is described in Chapters 6 and 7. Doppler parameters, which can be employed to evaluate systolic and diastolic dysfunction in cardiomyopathy, are listed in Table 18.4. Stroke volume can be determined by recording the time velocity integral (TVI) in the left ventricular outflow tract which, when multiplied by the cross-sectional area of the left ventricular outflow tract, provides actual volume of flow. Figure 18.13 schematizes this concept, and Figure 18.14 shows examples of left ventricular outflow tract TVI in patients with dilated cardiomyopathy and varying degrees of systolic dysfunction. In the bottom panel, note the alternating value of outflow TVI, which
corresponds to clinical pulsus alternans, a sign of advanced ventricular dysfunction. Once per-beat stroke volume has been determined, cardiac output can be calculated as the product of the heart rate and forward stroke volume. This calculation assumes that aortic insufficiency is not present. The major source of error in this calculation is the measurement of left ventricular outflow tract area, which relies on the square of the radius. For any individual patient, one can assume the outflow tract area remains a constant, and, therefore, comparison of the TVI alone provides a reliable means for comparing the left ventricular stroke volume at different time points.








Table 18.4 Role of Doppler Echocardiography in Cardiomyopathy










































































Assessment of forward flow



Doppler-based left ventricular outflow tract time velocity integral (TVI)



Volume-based left ventricular stroke volume



Cardiac output


Assessment of diastolic properties of the left ventricle



Mitral inflow pattern




E/A ratio





Response to Valsalva maneuver




Deceleration time




Dispersion of E-wave velocity




Isovolumic relaxation time




Color Doppler M-mode velocity of propagation (Vp)



Pulmonary vein flow




Systolic/diastolic flow ratio




Pulmonary vein A-wave duration



Annular Doppler tissue imaging




e′/a′ ratio




E/e′ ratio


Assessment of diastolic properties of the right ventricle



Doppler flow in the hepatic veins



Superior vena caval Doppler flow







FIGURE 18.12. Tissue tracking performed for longitudinal strain in apical long-axis, four- and two-chamber views in a patient with a nonischemic dilated cardiomyopathy and ejection fraction of 23%. The data were extracted from a three-dimensional data set. The tissue tracking for longitudinal strain in the apical two-chamber view is presented along with the graphs of six individual segments in the upper right. The lower right is a bull’s eye diagram of peak systolic strain in all 17 segments. Global strain was -8.6%, which is reduced, and in line with the patients ejection fraction of 23%. Note in graphs of individual segments, the limited degree of dyssynchrony among segments based on the time to peak negative strain. AVC, aortic valve closure; GLPS, global longitudinal peak strain.






FIGURE 18.13. Schematic illustration outlining determination of stroke volume (SV) in the left ventricular outflow tract from which cardiac output (CO) can also be obtained. The crosssectional area (CSA) can be calculated from the outflow tract radius. Pulsed Doppler is used to determine the time velocity integral (TVI) of flow. Calculation of SV, flow, and CO are as noted. HR, heart rate.

A final means for assessing left ventricular systolic function is calculation of the left ventricular dP/dt (see Chapter 6 for detailed methodology). This can be done from inspection of the continuous wave Doppler profile of mitral regurgitation. To perform this calculation, the sweep speed should be set at 100 mm/sec and a high-quality Doppler signal acquired with the continuous wave beam aligned parallel to the direction of flow. Figure 18.15 illustrates the range of left ventricular dP/dt encountered in patients with dilated cardiomyopathy. This
noninvasively determined dP/dt correlates well with values determined by cardiac catheterization, and dP/dt <600 mm Hg/sec has been associated with a worsened prognosis.






FIGURE 18.14. Left ventricular outflow tract time velocity integral (TVI) recorded in three patients with cardiomyopathy and reduced forward stroke volume. In the upper panel, note the marked decrease in TVI of 6.0 cm with less reduction in the middle panel. The bottom panel was recorded in a patient with severe left systolic dysfunction and reveals beat-to-beat variability in both the peak velocity and TVI which is a Doppler correlate of pulsus alternans, a clinical finding noted in advanced systolic dysfunction.


Assessment of Diastolic Function

Assessment of diastolic function in dilated cardiomyopathy provides valuable clues to the pathology underlying the development of symptoms. Currently, this is most commonly evaluated with Doppler interrogation of mitral inflow patterns combined with Doppler tissue imaging of mitral annular velocity. One M-mode finding has retained clinical relevance, which is the B-bump of mitral valve closure (Fig. 18.7). The B-bump is associated with elevated left atrial pressure, which in turn reflects a left ventricular end-diastolic pressure, typically exceeding 20 mm Hg. When combined with a suspected pseudonormal pattern of mitral valve inflow, it may provide added information regarding elevated diastolic pressures.

A hierarchy of diastolic flow profiles can be seen when interrogating the mitral valve in patients with dilated cardiomyopathy. These are schematized in Figure 18.16. As discussed in Chapter 7, it is important to integrate multiple observations of diastolic function to reliably determine the status of left atrial filling pressures and overall diastolic function. The echocardiographic and Doppler parameters that can be used to evaluate diastolic dysfunction in dilated cardiomyopathy are listed in Table 18.4. There are several parameters that should be obtained in all patients with cardiomyopathy, including mitral valve inflow patterns and Doppler tissue imaging for annular velocity.

Pulmonary vein flow Doppler recordings can be obtained from an apical view in most patients. Normal pulmonary vein flow occurs in both ventricular systole and diastole, and there is a brief retrograde flow that corresponds to atrial contraction (A-wave reversal). Figure 18.16 schematizes the progressive decrease in systolic flow and the increasingly prominent A-wave reversal with progressively more severe diastolic dysfunction. Because of its ease of acquisition and quantitative nature, Doppler tissue imaging of the mitral annulus has largely supplanted pulmonary vein flow analysis in most laboratories.






FIGURE 18.15. Examples of left ventricular dP/dt calculated from continuous wave Doppler of mitral regurgitation in three patients with dilated cardiomyopathy and varying degrees of left ventricular systolic dysfunction. A: Left ventricular dP/dt is relatively preserved at 967 mm Hg/sec. B, C: Moderate and marked reduction in left ventricular dP/dt is noted.

As noted in Figure 18.16, there is a hierarchy of abnormalities of diastolic function beginning with delayed relaxation and progressing to irreversible end-stage “restrictive” physiology that implies markedly elevated left ventricular diastolic pressure. Many patients with intermediate levels of diastolic
dysfunction will have a pseudonormal pattern in which the mitral E/A ratio is normal in the presence of diastolic dysfunction. This pattern can be seen either as the patient progresses from mild diastolic dysfunction to more severe stages (grades 1 to 3 in Fig. 18.16) or as a patient is treated and has reduced left ventricular diastolic pressures and improves from grade 3 to 1. There are several ancillary measures that can help identify the pseudonormal pattern, including evaluating pulmonary vein flow, Doppler tissue imaging of the mitral annulus (Figs. 18.17 and 18.18), or reevaluating the mitral inflow pattern during the Valsalva maneuver. During the Valsalva maneuver, flow into the left heart is reduced and left atrial and ventricular diastolic pressure is decreased, resulting in a reduction in the E-wave velocity and reversal of the pseudonormal E/A ratio to reveal a pattern of abnormal relaxation (Fig. 18.19). As discussed in Chapter 7, these findings are accurate in the patient with systolic dysfunction but may not be relevant in disease-free individuals.






FIGURE 18.16. Schematic of different Doppler patterns seen in healthy subjects and patients with varying stages of diastolic dysfunction. Top: Mitral inflow recorded from the apex of the left ventricle. Middle: Pulmonary vein flow. Bottom: Doppler tissue imaging of the mitral valve annulus. The appearance of grade 4 dysfunction is similar to that of grade 3. Clinically, grade 4 is considered irreversible, whereas the grade 3 pattern may revert to grade 2 with maneuvers that reduce left ventricular filling acutely or after successful therapy. See text for further details.






FIGURE 18.17. Echocardiographic images recorded in a patient with a dilated cardiomyopathy with an end-diastolic volume of 217 mL and an ejection fraction of 44%. The left atrium is dilated with a volume of 72 mL. Note the normal mitral valve E/A ratio but the reduced annular velocities and the blunted S wave of the pulmonary vein flow, all of which are consistent with diastolic dysfunction.






FIGURE 18.18. Mitral inflow pattern (A) and annular Doppler tissue imaging velocities (B) recorded in a patient with diastolic dysfunction. Note the normal mitral valve E/A ratio but the reduced e′/a′ ratio, implying diastolic dysfunction. In this example, the mitral E velocity is 90 cm/sec and the annular e′ velocity is approximately 5 cm/sec. The ratio E/e′ is 18, implying elevated left atrial pressure.

By combining the mitral valve inflow pattern with information from Doppler tissue imaging of the annulus, an index of
mitral valve (E) to annular E velocity (e′) can be obtained (Figs. 18.18 and 18.20). This index (E/e′) has been reported to be linearly related to left atrial filling pressure. The majority of individuals with E/e′ >15 have elevated pulmonary papillary wedge pressures and individuals with E/e′ ≤8 generally have low left atrial filling pressures. E/e′ values between these values are associated with a broad range of filling pressures. This measure appears independent of heart rate and, because it relies only on early filling velocities, is also valid in patients with atrial fibrillation. Recent data have suggested that this relationship may be substantially less robust in clinical practice than initially reported, especially in patients with severe left ventricular dysfunction.






FIGURE 18.19. Effect of the Valsalva maneuver on the mitral inflow pattern in a patient with grade 2 diastolic dysfunction. A: Note the normal E/A ratio. During the Valsalva maneuver (B), left atrial and left ventricular filling is diminished and a reversed E/A ratio is uncovered.






FIGURE 18.20. Mitral inflow and annular velocities recorded in a patient with an end-stage dilated cardiomyopathy. Note the E velocity of 110 cm/sec with an e′ of 6 cm/sec. E/e′ ratio is 18, suggesting elevated left atrial pressure. Also note the pathologically reduced systolic velocities of the mitral annulus.

Other modalities that can be used to evaluate diastolic dysfunction include color M-mode echocardiography of mitral valve inflow. From this, the velocity of propagation of inflow (Vp) can be calculated from the slope of the leading edge of the M-mode color flow signal. In normal hearts, Vp exceeds 50 mm/sec, with progressively lower Vp implying delayed relaxation and diastolic dysfunction. Measurement of Vp appears to be relatively preload independent. Figure 18.21 is a color Doppler M-mode image recorded in a patient with marked systolic and diastolic dysfunction. In Figure 18.21A, a normal mitral valve inflow pattern is noted for comparison. With diastolic dysfunction, there is a reduction in the velocity of inflow that is seen as a flattened slope of the mitral valve color flow profile and a decrease in depth toward the apex to which the flow propagates in an organized manner.


Myocardial Performance Index

The myocardial performance index is a unitless number reflecting global left ventricular systolic and diastolic performance. It is defined as the ratio of the total isovolumic times (isovolumetric contraction and relaxation) to ejection time (Figs. 18.22 and 18.23). It is calculated from Doppler tracings of the left ventricular outflow tract and mitral valve inflow. Normally, this value is 0.40 or less, with increasing values representing progressively worse left ventricular performance. It has been shown to provide independent prognostic information in patients with heart failure due to dilated cardiomyopathy.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 22, 2016 | Posted by in CARDIOLOGY | Comments Off on Dilated Cardiomyopathies

Full access? Get Clinical Tree

Get Clinical Tree app for offline access